文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛儿科与产科急症

儿童创伤相关急性呼吸窘迫综合征患者体外膜氧合结局

Outcomes of Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome in Pediatric Trauma Patients.
PubMed 文献 · Crit Care Explor · 2024-09-10
一句话结论儿童创伤后ARDS患者使用ECMO与未使用ECMO的院内死亡率无显著差异(10.0% vs 20.0%;p=0.302)。

该观察性队列研究基于创伤质量改进计划数据库2017至2019年及2021至2022年数据,纳入所有18岁以下创伤后发生ARDS的住院患儿,共453例符合条件,经倾向性评分匹配得到50对患者。比较ECMO组与未使用ECMO组的院内死亡率和并发症,结果显示两组在年龄、种族、性别、损伤严重度评分、格拉斯哥昏迷评分、损伤机制及合并症方面无显著差异;院内死亡率(10.0% vs 20.0%;p=0.302)、急性肾损伤(12.0% vs 2.0%;p=0.131)、肺炎(10.0% vs 20.0%;p=0.182)及深静脉血栓(16% vs 6%;p=0.228)均无显著差异。作者认为需要更大样本研究以明确ECMO在该人群中的确切获益。

要点

  • 儿童创伤后ARDS患者中,ECMO组与未使用ECMO组院内死亡率无显著差异(10.0% vs 20.0%;p=0.302)。
  • 两组急性肾损伤发生率无显著差异(ECMO+组12.0% vs ECMO-组2.0%;p=0.131)。
  • 两组肺炎发生率无显著差异(ECMO+组10.0% vs ECMO-组20.0%;p=0.182)。
  • 两组深静脉血栓发生率无显著差异(ECMO+组16% vs ECMO-组6%;p=0.228)。
  • 作者认为需要更大样本量研究以明确ECMO在儿童创伤后ARDS患者中的确切获益。

适用人群与场景

  • 创伤质量改进计划数据库2017至2019年及2021至2022年收录的所有18岁以下创伤后住院并发生急性呼吸窘迫综合征的患儿。

研究设计与关键结果

  • 研究类型为观察性队列研究,数据来自创伤质量改进计划数据库2017至2019年及2021至2022年,453例符合条件,经倾向性评分匹配得到50对患者。
  • ECMO+组与ECMO-组年龄分别为16岁(四分位距13.25-17岁)与16岁(14.25-17岁),无显著差异。
  • ECMO+组与ECMO-组白人比例分别为62.0%与66.0%,男性比例分别为78%与76%,损伤严重度评分分别为23(四分位距9.25-34)与22(9.25-32),格拉斯哥昏迷评分分别为15(四分位距3-15)与13.5(3-15),损伤机制及合并症均无显著差异。
  • ECMO+组与ECMO-组院内死亡率分别为10.0%与20.0%,无显著差异(p=0.302)。
  • ECMO+组与ECMO-组急性肾损伤发生率分别为12.0%与2.0%,无显著差异(p=0.131);肺炎发生率分别为10.0%与20.0%,无显著差异(p=0.182);深静脉血栓发生率分别为16%与6%,无显著差异(p=0.228)。

证据类型、等级与局限

  • 证据类型为观察性队列研究。
  • 作者在结论中提出需要更大样本量研究以明确ECMO在儿童创伤后ARDS患者中的确切获益。

对床旁实践的改变

  • 儿童创伤后ARDS患者使用ECMO与未使用ECMO的院内死亡率及并发症无显著差异。
  • 作者认为需要更大样本量研究以明确ECMO在该患者群体中的确切获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Acute respiratory distress syndrome (ARDS) is associated with high mortality and morbidity. Extracorporeal membrane oxygenation (ECMO) is one of the interventions that have been in practice for ARDS for decades.

OBJECTIVES: The purpose of the study was to investigate the outcomes of ECMO in pediatric trauma patients who suffered from ARDS.

DESIGN: Observational cohort study.

SETTING AND PARTICIPANTS: The Trauma Quality Improvement Program database for years 2017 to 2019 and 2021 through 2022 was accessed for the study. All children younger than 18 years old who were admitted to the hospital after trauma and suffered from ARDS were included in the study. Other variables included in the study were patients' demographics, clinical characteristics, Injury Severity Score (ISS), Glasgow Coma Scale (GCS) score, comorbidities, and outcomes.

MAIN OUTCOMES AND MEASURES: ECMO is the exposure, and the outcomes are in-hospital mortality and hospital complications (acute kidney injury [AKI], pneumonia and deep vein thrombosis [DVT]).

RESULTS: Of 453 patients who qualified for the study, propensity score matching found 50 pairs of patients. There were no significant differences identified between the groups, ECMO+ vs. ECMO- on patients' age in years (16 yr; interquartile range [IQR], 13.25-17 yr vs. 16 yr [14.25-17 yr]), race (White; 62.0% vs. 66.0%), sex (male; 78% vs. 76%), ISS (23 [IQR, 9.25-34] vs. 22 [9.25-32]), and GCS (15 [IQR, 3-15] vs. 13.5 [3-15]), mechanism of injury; and comorbidities. There was no difference between the groups, ECMO+ vs. ECMO-, in-hospital mortality (10.0% vs. 20.0%; p = 0.302), hospital complications (AKI 12.0% vs. 2.0%; p = 0.131), pneumonia (10.0% vs. 20.0%; p = 0.182 > ), and DVT (16% vs. 6%; p = 0.228).

CONCLUSIONS AND RELEVANCE: No difference in mortality was observed in injured children who suffered from the ARDS and were placed on ECMO when compared with patients who were not placed on ECMO. Patients with trauma and ARDS who require ECMO have comparable outcomes to those who do not receive ECMO. A larger sample size study is needed to find the exact benefit of ECMO in this patients' cohort.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Ahmed N, Kuo YH. Outcomes of Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome in Pediatric Trauma Patients. Crit Care Explor. 2024. PMID: 39254656. doi:10.1097/CCE.0000000000001150

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。